Skip to main content

Table 6 In vitro antifungal agent susceptibilities of Candida and Cryptococcus isolates collected by the SENTRY Program in 2006 to 2007 [39].

From: Epidemiology and antifungal resistance in invasive candidiasis

Species (no. of isolates) and drug

MIC50/MIC90 (μg/ml)

MIC range (μg/ml)

 

% by categorya

 
   

S

SDD

R b

C. parapsilosis (238)

     

Anidulafungin

2/2

0.03-4

95.4

-

4.6

Caspofungin

0.5/1

0.06-4

99.6

-

0.4

Amphotericin B

1/1

0.25-1

99.6

-

0.4

5-FC

≤0.5/≤0.5

≤0.5- > 64

98.7

(0.0)

1.3

Fluconazole

1/4

≤0.5-32

96.6

3.4

0.0

Itraconazole

0.25/0.25

≤0.015-2

40.8

57.1

2.1

Posaconazole

0.12/0.25

≤0.06-1

-

-

-

Voriconazole

≤0.06/0.12

≤0.06-2

99.6

0.4

0.0